BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman
San Francisco, California-- (Newsfile Corp. - February 20, 2025) - BioAge Labs, Inc. (NASDAQ: BIOA) is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase ...
来自MSN1 天
NFL makes decision on Jameson Williams gun case
Detroit Lions wide receiver Jameson Williams has already been suspended twice during his NFL career, but he will not face any ...